Market

Catalent Shows Market Leadership With Jump To 81 RS Rating

Catalent (CTLT) saw a welcome improvement to its Relative Strength (RS) Rating on Monday, rising from 78 to 81.




X



When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

IBD’s unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock’s price action over the last 52 weeks matches up against other publicly traded companies.

Over 100 years of market history shows that the stocks that go on to make the biggest gains typically have an 80 or higher RS Rating in the early stages of their moves.


Looking For The Best Stocks To Buy And Watch? Start Here


Catalent is building a cup without handle according to a Marketsmith weekly chart, with a 127.78 entry. See if it can break out in volume at least 40% above average. The daily chart shows a sucer with handle, offering an earlier entry point.

Catalent saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 40% to 64%. Revenue rose from 26% to 38%. The next quarterly numbers are expected on or around Aug. 31.

The company holds the No. 6 rank among its peers in the Medical-Research Equipment/Services industry group. Charles River Labs International (CRL) and Avantor (AVTR) are also among the group’s highest-rated stocks.

YOU MIGHT ALSO LIKE:

Join IBD Live And Learn Top Chart-Reading And Trading Techniques From The Pros
MarketSmith’s Tools Can Help The Individual Investor
Profit From Short-Term Trends With SwingTrader
Get Timely Buy & Sell Alerts With IBD Leaderboard
Find The Best Long-Term Investments With IBD Long-Term Leaders

 

Most Related Links :
reporterwings Governmental News Finance News

Source link

Back to top button